News from magnolia medical technologies A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jan 24, 2023, 13:15 ET Large-scale, peer-reviewed study quantifies multiple devastating patient harms associated with blood culture contamination and most significantly, a 74% increase in risk of in-hospital patient mortality

Magnolia Medical Technologies, Inc. ("Magnolia Medical"), inventors of the Steripath® Initial Specimen Diversion Device® (ISDD®), the only FDA...

Jan 10, 2023, 13:15 ET Stanford Health Care Achieves Zero Blood Culture Contaminations and Near Elimination of False-Positive CLABSIs in Large-Scale Study Using the Steripath® Initial Specimen Diversion Device®

Magnolia Medical Technologies, Inc. ("Magnolia Medical"), inventors of the Steripath® Initial Specimen Diversion Device® (ISDD®) family of products,...

Sep 13, 2022, 13:15 ET Magnolia Medical Technologies Files for Permanent Injunction Against Infringing Kurin Lock Products

Magnolia Medical Technologies, Inc. ("Magnolia Medical"), inventors of the Steripath® Initial Specimen Diversion Device® (ISDD®) family of products,...

Aug 23, 2022, 13:15 ET Magnolia Medical's Steripath® Initial Specimen Diversion Device® Only Device Clinically Proven to Meet CDC's New Guidelines to Reduce Blood Culture Contamination

Magnolia Medical Technologies, Inc., commends the Center for Disease Control and Prevention (CDC) for releasing its new evidence-based guidelines,...

Jul 29, 2022, 09:30 ET Magnolia Medical Technologies Wins Patent-Infringement Lawsuit against Kurin, Inc.

A jury for the U.S. District Court of Delaware delivered two unanimous verdicts this week in favor of Magnolia Medical Technologies, Inc. ("Magnolia...

Jun 02, 2022, 13:15 ET Magnolia Medical Launches New Company Website to Educate Healthcare Providers on Blood Culture Contamination and to Increase Awareness of the Devastating Impact of Sepsis Misdiagnosis

Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform specifically indicated to reduce blood...

May 24, 2022, 13:20 ET Magnolia Medical Announces Successful FDA Field Inspection Results and Formal Warning Letter Close-Out

Magnolia Medical Technologies, Inc., ("Magnolia") inventors of the Steripath® Initial Specimen Diversion Device® (ISDD®), today announced that it has ...

May 05, 2022, 13:15 ET Newly Released CLSI National Blood Culture Guidelines Identify Best Practices and Evidence-Based Technology Solutions Such as Steripath® to Improve Patient Safety and Outcomes

Magnolia Medical Technologies, Inc., commends Clinical Laboratory Standards Institute (CLSI) for establishing a goal of 1% blood culture...

Apr 06, 2022, 13:15 ET Novel Study Demonstrates the Hospital-Wide Impact of the Steripath® Initial Specimen Diversion Device® on Blood Culture Contamination Rates and Sepsis Testing Accuracy at WVU Medicine - United Hospital Center

Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture...

Feb 16, 2022, 13:15 ET Magnolia Medical Announces $46 Million Growth Equity Financing

Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture...

Dec 15, 2021, 13:15 ET Magnolia Medical, MHA Solutions, and Healthcare Providers Insurance Company Enter into an Exclusive, Endorsed Agreement for the Steripath® Initial Specimen Diversion Device®

Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture...

Dec 07, 2021, 13:15 ET Members of Congress Urge CMS to Take Action to Reduce Preventable False-Positive Diagnostic Test Results for Sepsis

Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture...

Nov 11, 2021, 13:15 ET Magnolia Medical Announces Expansion of Its Extensive Clinical Evidence Library with Six Steripath® ISDD® Studies in 2021 Demonstrating Zero or Near-Zero False Positive Sepsis Test Results

Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture...

Oct 28, 2021, 13:15 ET Magnolia Medical Further Strengthens Executive Management Team with the Addition of Silicon Valley Financial Leader, Patrick O'Malley, as Chief Financial Officer

Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture...

Oct 26, 2021, 13:15 ET Magnolia Medical Appoints Industry Veteran, Joseph Bishop, as the Senior Vice President of Operations and Product Development

Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture...

Oct 12, 2021, 13:15 ET Magnolia Medical Awarded National GPO and Value-Based Contract from Premier Inc. for Steripath® Initial Specimen Diversion Device®

Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture...

Aug 03, 2021, 13:15 ET New Congressional Directive for Improved VA Patient Care Enabled by Magnolia Medical's Sepsis Testing Accuracy Technology

Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture...

Jul 29, 2021, 13:15 ET Magnolia Medical's New Blood Culture Collection Technology Enables Children's Hospitals to Reduce Contamination Rates to Zero

Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture...

Jul 27, 2021, 13:15 ET Newsweek in Partnership with The Leapfrog Group Awards Magnolia Medical's Steripath Platform as Category-Exclusive Best Infection Prevention Product of 2021

Magnolia Medical announced today that Newsweek®, in partnership with The Leapfrog Group, an independent, nonprofit healthcare industry watchdog...

Jun 09, 2021, 13:15 ET Sepsis Testing Accuracy Technology Enables Enhanced Patient Safety, Experience and Satisfaction

Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture...

May 11, 2021, 13:15 ET Magnolia Medical Joins Emergency Nurses Association's Corporate Engagement Council as Category-Exclusive Member

Magnolia Medical Technologies, Inc. – inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture...

Apr 14, 2021, 13:15 ET Magnolia Medical Launches New "Diverted" Multi-Media Advertising Campaign to Educate Healthcare Providers on Benefits of Steripath®

Magnolia Medical Technologies, Inc. recently launched a new multi-media advertising campaign to promote the benefits of the Steripath® Initial...

Feb 11, 2021, 13:15 ET Stanford Health Care Presents Unprecedented Study Results with Steripath Gen2 ISDD to Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria

Magnolia Medical Technologies, Inc. – inventors of Steripath®, the only FDA-cleared device platform indicated to reduce blood culture contamination1...

Nov 11, 2020, 13:15 ET Magnolia Medical Appoints Renowned Clinical Microbiologist Gary V. Doern to Its Medical & Scientific Advisory Board

Magnolia Medical Technologies, Inc. today announced the appointment of Gary V. Doern, Ph.D., Professor Emeritus of Pathology, University of Iowa...

Oct 27, 2020, 13:15 ET Stanford Health Care Study Reports Zero Blood Culture Contaminations and False-Positive CLABSIs Using Steripath Gen2 ISDD

Magnolia Medical Technologies, Inc., inventors of Steripath®, the trusted solution for reducing blood culture contamination – today announced...